摘要
Diagnosis of tuberculosis can be difficult as advances in molecular diagnosis approaches(especially nanoparticles combined with high-throughput mass spectrometry for detecting mycobacteria peptide)and personalized medicine result in many changes to the diagnostic framework.This review will address issues concerning novel technologies from bench to bed and new strategies for personalized tuberculosis diagnosis.
基金
This paper was partially supported by the National Institutes of Health(grants Nos.R01AI113725 and R01HD090927).
